chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Change in taste; Developed taste aversion to seafood and eggs; Seafood and eggs; eating such foods caused nausea; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0172) via an unspecified route of administration in the left arm on 04May202 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included alopecia areata. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously took Bactrim on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May202, the patient experienced change in taste, developed taste aversion to seafood and eggs and eating such foods caused nausea. The clinical outcome of the events of change in taste, developed taste aversion to seafood and eggs and eating such foods caused nausea were not recovered.  No follow-up attempts are needed. No further information is expected.
Moderna COVID-19 EUA. Severe ringing in left ear the day after the vaccine, still ringing.
Tingling and numbness in bilateral lower extremities. Symptoms began 40 minutes after receiving vaccine (which was received on 12/18/20 at 10:50) and are still present at this time (12/19/20 at 13:35).  I have not received treatment for it.
Headache, Myalgia, Arthralgia, dizziness with exertion Narrative: within 24 hours developed fatigue, h/a, body aches, lightheaded with exertion.
Signs of fever and crying. Not looking good. Called doctor and nurse said to give a double dose of Motrin and call back the next day.
- 1st dose (3/19/21): low-grade fever for 48 hours - 2nd dose (4/19/21): high-grade (102-103) fever and loss of sense of taste
swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received the second dose of bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration in the Right Arm on Apr2021, as a single dose for COVID-19 immunisation. Medical history included non-hodgkin's lymphoma three times, stem cell transplant from an unknown date and cancer for 20 plus years. The patient's concomitant medications were not reported. The patient was transferred from another department to find out more information regarding his side effects that he is experiencing after the second dose of the Pfizer COVID-19 vaccine. He received his second dose of the Pfizer COVID-19 vaccine almost 3 weeks ago. He states that this Wednesday, 28Apr2021 it will be 3 weeks since his second dose. Two weeks after his second dose he started to develop swollen lymph nodes on his right collar bone and up the right side of his neck. He received his second dose injection "high up on my right arm." He states that the development of the swollen lymph nodes was kind of slow and not all of the sudden but it scared it him because this is the same sign of Non-Hodgkin's Lymphoma except it's a suddenly enlarged lymph node that seems to appear overnight. He states that he lost a night's sleep worrying about it even though the paperwork he received said that swollen lymph nodes are a potential side effect. He is requesting more information about this side effect. The seriousness criteria of the event was reported as non-serious by the health authority. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained .
Pt w/ arthralgias in hands/fingers/shoulders, knees. Swelling in hand
24 y.o. female presents with chief complaint of an itchy rash on her bilateral arms.  Onset was about 1 hour ago (5:30p).  The only inciting event she can think of was getting her first injection of the pfizer covid vaccine today about 2.5 hours prior (3p) to onset of symptoms.  She denies shortness of breath, nausea, throat tightness or facial swelling.   She has a history of latex allergy but no other known allergies. She used some diphenhydramine cream that provided minimal relief.
HEART PALPITATIONS, CHEST PAIN, HIGH BLOOD PRESSURE, FATIGUE, DIZZINESS
This patient is fully vaccinated for Covid-19 On 7/17/21 patient  was exposed to a family member who tested positive for Covid-19. On 7/21/21 patient tested positive for Covid-19
p/vax pt broke out in rash all over body; fingers tingle-goes away & comes back
1 hour post injection hot flashes for 12 hours 1 hours post injection migraine with nausea for 24 hours  Second shot: lot FE3592 on 09/11/2021 @ 05:00 PM cause a migraine for 7 days with nausea.
On 4/7/99, the pt developed rash characterized by fever of 102, diarrhea, and increased fussiness. Subsequently, the pt recovered from the episodes.
Initial unsolicited report received from physician on 07-Jul-2017. This case involves a 34 years old male patient who was vaccinated with 0.5 ml single dose of TYPHIM VI (Batch number: M15721M, expiry date and site of administration was not reported) intramuscularly on 30 June 2017. No known drug allergies, no history reactions to vaccines, no medical history other than history of anxiety/depression treated with very small dose of Zoloft. Patient received 10 mg SERTRALINE HYDROCHLORIDE (Zoloft) daily orally four years ago from depression and 400 mg dose of IBUPROFEN twice a day orally on 05 July 2017. On 05 July 2017 in the evening five days following the vaccination the patient had tactile fever. On 06 Jul 2017 in the night six days following the vaccination patient had fever including drenching sweats and chills. The patient relevant lab test was not reported. Patient received ibuprofen 400 mg at bedtime as a corrective treatment. (Self-treated with more ibuprofen). On 07 July 2017 Patient was recovered from events. (It was reported that by morning of 7 July 2017, subject was afebrile, energetic, had no other symptoms). List of documents held by sender: none.
I woke up and felt really sick and had a cough, sore throat, with a runny nose and congestion. I felt tired and achy my back and shoulders with no energy. I had a doctors tele visit. I went in to my doctors the next day and was tested for the COVID-19 virus and for influenza both tests were negative. I was told I had a virus that had to run its course. My cough went away but the fatigue and congestion has continued until the time of this report.
pt recv vax 1OCT97 & 6OCT97 pt exp macular rash over trunk more than 50 lesions, fever & runny nose;@ time of report pt rash had spread to lower extremities;
High fever, ER admission, clinic follow up ( decreased urine output, decreased appetite very fussy, fever up to 105, given Motrin/Tylenol)
Dizzy; Nausea; Vomit; Pain on all body; Frequent fall; Severe fatigue; Strange feeling; Abdominal pain on and off; Arrhythmia; This is a spontaneous report from a contactable physician. A 60-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in left arm on 11Feb2021 09:00 (batch/lot number was not reported) as single dose for COVID-19 immunisation. Medical history included (G60.9) PN - Peripheral neuropathy (SCT42658009), (M79.2) A Neuralgia (SCT16269008), (R55) Syncope (SCT271594007), (I10) HTN - Hypertension (SCT38341003), (R00.0) Tachycardia (SCT3424008), (E16.2) Hypoglycemia (SCT302866003), (R55) Vasovagal symptom (SCT248229009), (M25.50) Joint pain (SCT57676002), (F41.9) Anxiety (SCT48694002), (K21.9) Acid reflux (SCT235595009), and (M06.4) Polyarthritis (SCT416956002); all were current or ongoing. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 on 12Jan2021 for COVID-19 immunization (product: COVID 19, brand: Pfizer, administration time: 09:00 AM, route: intramuscular, vaccine location: left arm). On 11Feb2021 11:00, the patient experienced dizzy, nausea, vomit, pain on all body, frequent fall, severe fatigue, strange feeling, abdominal pain on and off, and arrhythmia. The AEs resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage. There were no treatments given for the events. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID post vaccination. The patient has no known allergies. No other vaccines received within four weeks prior to COVID vaccine. The events were reported as serious and disabling. The patient has not recovered from all the events.   Information on the lot/batch number has been requested.; Sender's Comments: Drug causality for suspect drug  in the onset of the reported events cannot be excluded assuming a plausible temporal association and considering the known safety profile of the product.    The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Left arm swelled up within a few hours of receiving vaccine. The patient treated with ice. The swelling went down after 3 days but was left with red, itchy arm. She is taking cetirizine to treat the pruritus.
Within 10 minutes post vax, the pt felt nose swelling inside and tightness of chest. Pt felt bad all day. On the 6th, the pt awoke with diarrhea and aching, arm still red, painful, and swollen. Went back to physician. He prescribed Cefadroxil in case it was an infection. Pt continued with diarrhea and his stomach pain became excruciating. The pt stopped eating and pushing fluids. Went to ER and put on IV fluids. Physician felt the pt was experiencing a toxic reaction. Prescribed Flagyl for antibiotic reaction. Stayed on clear liquids. He kept feeling worse, weak, faint, and confused. Physician sent him to ER again where they admitted him to the hospital. He was put on IV and liquid diet, meds, and soft diet. Pt still not feeling well.  Diagnosed with irritable bowel syndrome.
My lips swelled, I called Covid hotline and they told me to to the Emergency room. The Dr. hooked me took my vitals for about an hour then gave me Benadryl, it was resolving on its own. I saw an allergist on 4/21. Allergist wanted me to take Zyrtec take it 8 night before and 8 am the day of 2nd dose.
nosebleed/she experienced a nosebleed; This non-serious case was reported by a consumer via call center representative and described the occurrence of epistaxis in a 73-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 04-OCT-2023, the patient received Arexvy (right arm). On 05-OCT-2023, 1 days after receiving Arexvy, the patient experienced epistaxis (Verbatim: nosebleed/she experienced a nosebleed).  The outcome of the epistaxis was unknown.   It was unknown if the reporter considered the epistaxis to be related to Arexvy.     It was unknown if the company considered the epistaxis to be related to Arexvy.   Additional Information: GSK receipt date: 05-OCT-2023 and 09-OCT-2023 The patient reported that she received a dose of Arexvy yesterday afternoon and when she woke up to blow her nose today, she experienced a nosebleed. The reporter did not consente to follow up.
Migraines; Head pressure; Vertigo; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 23Jul2021 13:15 (Lot number: FA7485) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "unspecified goiter" (unspecified if ongoing); "anemic" (unspecified if ongoing); "tree nuts allergy" (unspecified if ongoing). Concomitant medication(s) included: ZYRTEC ALLERGY; ABC SPECTRUM [ASCORBIC ACID;BETACAROTENE;BIOTIN;BORON;CALCIUM;CALCIUM PANTOTHENATE;CHLORINE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;MOLYBDENUM;NICKEL;NICOTINAMIDE;PHOSPHORUS;PHYTOMENADIONE;POTASSIUM;PY; IBUPROFEN. Past drug history included: Zpak, reaction(s): "Known Allergy-Zpak". The following information was reported: MIGRAINE (non-serious) with onset 25Jul2021, outcome "not recovered", described as "Migraines"; HEAD DISCOMFORT (non-serious) with onset 25Jul2021, outcome "not recovered", described as "Head pressure"; VERTIGO (non-serious) with onset 25Jul2021, outcome "not recovered", described as "Vertigo". The events "migraines", "head pressure" and "vertigo" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of migraine, head discomfort, vertigo.  Additional Information: Additional information: Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Treatment received for the adverse event was ibuprofen 800 mg. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient has not medication, lab test or health problems since were than one year previous to vaccination. Device Date was 27Oct2021.  No follow-up attempts are possible. No further information is expected.
Accidental overdose; Patient also stated that not immunocompromised; Developed a fever of 103.0 F; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Accidental overdose), OFF LABEL USE (Patient also stated that not immunocompromised) and PYREXIA (Developed a fever of 103.0 F) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 22-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Accidental overdose), OFF LABEL USE (Patient also stated that not immunocompromised) and PYREXIA (Developed a fever of 103.0 F). On 22-Oct-2021, ACCIDENTAL OVERDOSE (Accidental overdose) and OFF LABEL USE (Patient also stated that not immunocompromised) had resolved. At the time of the report, PYREXIA (Developed a fever of 103.0 F) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Oct-2021, Body temperature: (High) Fever of 103.0F..         No concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2021-363280 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow-Up information received: Events (incorrect dose administered and off label use) added and Email Id updated.
Patient developed low grade fever, chills, body aching, RUQ pain, malaise, fatigue on 5/17/21. Saw PCP on 5/21/21 found to be anemic, went to ER and was admitted on 5/22/21. Splenic infarcts, Splenomegaly, and Hepatomegaly. Diagnosed with autoimmune Hepatitis after multiple tests such as bone marrow biopsies, CT scans, and labs. She also developed sinus bradycardia pauses and bouts of SVT.
Post vax, the pt developed a fever and had aches and was in bed for 2-3 days. The pt sought unspecified medical attention.
Approximately 2 hours after injections client complained of cough, vomiting which led to wheezing. Evaluated at ER and transferred with overnight stay for observation. Denied itching/hives. Medical records state dyspnea, headache. msv
Woke up in the am and whole face "felt numb"; diarrhea x 1 day.
Patient had a seizure about 5 minutes after vaccination was administered. Patient has a history of seizure according to the husband. We were not sure if the seizure started because of the vaccine or because of nervousness before getting the vaccination.
I got my vaccine around 3:00 pm, on March 16, everything seemed fine until around 2 or 3 am, the following morning,  I woke up unable to breathe through my throat nor my nose,   My throat was  complete closed,  this  reaction lasted about 15to  20 seconds,
Hard knot at injection site the next morning - pt was informed that was a listed side effect and to let us know the next day if it subsides or not.
pt recv vax 13OCT97 & pt exp swelling in the lt leg where inj was given;pt devel a high fever greater than 104 & 14OCT97 pt was hosp;it was reported that the pt was prev hosp for pneumonia & empyema;
Information has been received from a Licensed Practical Nurse (L.P.N.) concerning a 72 year old white female patient with anxiety, cholesterol, hypertension and diabetes mellitus who in 2003 was vaccinated with a dose of Pneumovax 23 and on 15-NOV-2007 received IM another dose of Pneumovax 23 lot # 654977/0888F. Concomitant therapy included EFFEXOR, LIPITOR, fosinopril sodium, lorazepam and metformin. The nurse reported that on 16-NOV-2007 the patient called and complained of discomfort in inner aspect of right arm with redness and warmth (Bicep). Injection site was unremarkable. Azithromycin (Z pack) was given to her and warm compress was recommended. The patient recovered. The reporter felt that the patient getting Azithromycin (Z pack) and recommending her warm compress was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested.
symptoms started 1 day after vaccine. Got shot at 11 am. started out at 1pm next day as tooth pain, then moved to jaw, then radiated up to side to ear, then across forehead (took advil 400mg about 3:30pm), and currently 7:17pm and not feeling the side effects.
tiredness; headache; muscle pain; chills; feeling unwell; injection site soreness; This is a spontaneous report from a contactable nurse (patient herself). A 76-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 31Jan2021 at 08:00 AM (at the age of 76-year-old) at a single dose for COVID-19 immunisation. The patient's medical history included coronary artery disease (CAD), hypothyroidism, and sleep apnea. Concomitant medications included levothyroxine, carvedilol, latanoprost, and amlodipine besilate (AMLOD). The patient previously took meperidine (DEMEROL) and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient experienced tiredness, headache, muscle pain, chills, feeling unwell, and injection site soreness on 31Jan2021 09:00 PM. The patient had not taken any other vaccine in 4 weeks. The outcome of the events was recovering. There was no treatment given due to the events. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  Information on the Lot/Batch number has been requested.
lump, redness & swelling rt thigh localized;?early cellulitis treated w/augmentin x 10 days;
Headache, arm pain,muschle pain, weak, exhaustation, sore throat, dizziness, nublated vision
She has some symptoms, not severe, but minor; fatigue, headache, sore throat.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 18-JAN-2016, the patient was vaccinated with VARIVAX (Merck) (strength, dose, route unknown) (lot# L019130, expiration date 27-MAY-2015 and lot# L026407, expiration date 15-JUL-2015) which were improperly stored (incorrect product storage) (Temperature: 9.5 F, Time frame: 2 hours). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
1 day after vaccines on 5/6, patient's mom noted erythematous macular-papular lesion on right arm which increased in size by 5/8 to a welt of 5.25"x4 7/8" on right upper arm which is warm to touch and swollen.
allergic reaction; rash all over her stomach, chest; Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction), RASH (rash all over her stomach, chest) and VACCINATION SITE RASH (Rash at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction), RASH (rash all over her stomach, chest) and VACCINATION SITE RASH (Rash at injection site). At the time of the report, HYPERSENSITIVITY (allergic reaction), RASH (rash all over her stomach, chest) and VACCINATION SITE RASH (Rash at injection site) had resolved.            The patient was fine after the first dose. After the second dose, the patient had had an allergic reaction, had a rash all over her stomach, chest and injection site that went away with some cream. No concomitant medications reported.
Severe hives on all of body but face. Could barely see my skin through the hives.  Also; fever, chills, body aches so bad I thought I needed to go to the ER
Information has been received from a nurse practitioner concerning a 17 year old female patient with attention deficit disorder who had been vaccinated with all three doses of GARDASIL, the third 0.5ml dose was given intramuscularly in March 2008. Concomitant therapy included YAZ and ADDERALL TABLETS (manufacturer unspecified). The patient's mother reported that the patient started experiencing heart palpitations. The patient did not seek medical attention. No laboratory diagnostic study was performed. The patient's outcome was unknown. The nurse thought that it might have been her other medication (ADDERALL TABLETS) for attention deficit disorder that caused that. Additional information has been requested.
Patient reports about 35 minutes after vaccine was given her throat felt like it was swelling up and she was having trouble breathing. She drank some water and it improved. The sensation of swelling or her throat and trouble breathing occurred over 2-3 hours and then went away. she did not seek medical attention and only notified us when she came back for her second dose.
PC from client on 08/01/02 stating "has had joint pain, swelling and redness in hands and knees which occurred approx (2) days ago. Advised to call Dr who ordered MMR to report symptoms and advise on treatment . 08/21/02-Follow-up pc to client, Still some tenderness, Client spoke with doctor -"no follow-up recommended at this time".
This spontaneous report was received from a medical assistant refers to unspecified patients of unknown age and gender. Information regarding patients' medical history, concurrent condition, drug reactions/allergies and concomitant therapy were not provided. On unspecified dates between 11-SEP-2016 and 14-SEP-2016, the patients were vaccinated with unspecified doses of improperly stored VAQTA (lot # L036878, expiry date: 26-MAY-2017; lot # 0097876, expiry date: 26-MAY-2017; lot # L015468, expiry date: 20-JUL-2017). No adverse reactions were reported. This is one of the five reports received from the same reporter. Additional information has been requested.